0
Erbe participants
Movember campaign
0
expected donation
amount
0
Pictures in the
gallery
JOIN IN!
We will donate 100 € to the Movember Foundation for every moustache one of our employees grows. We want to raise as many donations as possible so please join in!
Our Movember campaign begins on November 1st and ends on November 30th, 2020. Registration ends on November 4th.
Please consult the official Styleguide to find out which types of moustaches fit the bill.
WHAT IS THE MOVEMBER® FOUNDATION?
It is a leading charitable organization that seeks to change the face of men’s health. The focus lies on prostate and testicular cancer, mental health and suicide prevention.
WHAT IS THE MOVEMBER® FOUNDATION?
It is a leading charitable organization that seeks to change the face of men’s health. The focus lies on prostate and testicular cancer, mental health and suicide prevention.
WHAT MOTIVATES US TO JOIN IN AND DONATE?
The focus of the campaign lies on prostate and testicular cancer, mental health and suicide prevention.
We from Management are all joining in. Why don’t you do the same for a good cause?
„We took part and grew a moustache from November 1-30.“
The gallery is updated continuously. You may need to reload the page (F5 or Ctrl+F5) to see the latest photos.
Sandeep Madakkara
Peter Stein
Leon Erbe
Christoph Rudolf
Prevention helps save lives. This goes for men’s health too.
On this subject, you can view the video interviews with Katharina Busch and the urologists Prof. Dr. Christian Schwentner, Dr. Roger Riexinger and Reza Arbabi.
Prostate screening and men's health - opportunities and obstacles
Prof. Christian Schwentner, MD, Chief physician Urological Clinic, Diakonie Hospital Stuttgart, Germany
Prostate and testicular cancer: risk, screening and treatment
Roger Riexinger, MD, Leading senior physician, Department of Urology, Nagold Hospital, Germany
Mental health and working life
Katharina Busch, Company physician at Erbe
From the urological practice: symptoms, procedure for early detection of prostate and testicular cancer
Reza Arbabi, Specialist in Urology, Practice in Tuebingen, Germany
